NCT03020251Completed
Effects of Preoperative Rehabilitation in Patients Resected for Lung Cancer
Source: ClinicalTrials.gov · Last updated 13 Mar 2026
Brief summary (registry, in English)
This randomized controlled trial will evaluate the effect of a preoperative rehabilitation program at home in patients resected for lung cancer, comparing a control group (C group) receiving only chest physiotherapy and a rehabilitation group (R group) receiving both a training program at home and chest physiotherapy
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 90 (actual)
- First submitted
- 20 Dec 2016
- Start date
- 12 May 2017
- Primary completion date
- 13 Feb 2026
- Lead sponsor
- Centre Jean Perrin
- Diseases
- Lung cancer
- NCT number
- NCT03020251
What you commit to
- Study type: Interventional
- Participants enrolled: 90
- From 12 May 2017 to the primary completion date, 13 Feb 2026
- 6 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Patient with ventilatory assistance at home (oxygen therapy or noninvasive ventilation (NIV))
Other illness
- Presenting cardiac or vascular contraindication to achieve the readaptation program
Other
- Patients refusing to participate
- COPD stage 1 Gold (VEMS \>= 80% of the theoretical value)
- Presenting an operating contraindication during the initial maximal exercise test
- Patient living alone at home
- With exercise hypoventilation (PaCO2 \>45 mmHg)
- Cognitive difficulty
- unable major
- pregnancy,
- patients deprived of liberty by a court or administrative decision
Who the study is looking for
- Patients diagnosed for lung cancer (or highly suspicious for cancer tumor) eligible for resection surgery (lobectomy or pneumonectomy)
- Age \> 18 years
- Presence of Chronic Obstructive Pulmonary Disease (COPD) stages 2-4 of Gold (forced expiratory volume (FEV )/ forced vital capacity (FVC) \<70%, FEV \<80% of predicted) and Exertional dyspnea stage MMRC (Medical Research Council) \> 1
- Patients must provide written consent
- Member of social security scheme
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (6)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| CHU Clermont Ferrand, Gabriel Montpied, service de médecine du sport et explorations fonctionnelles, Coordinator of this site? Confirm its status | Clermont-Ferrand | France | Unknown status |
| Centre de Recherche en Nutrition Humaine Coordinator of this site? Confirm its status | Clermont-Ferrand | France | Unknown status |
| Centre Jean Perrin Coordinator of this site? Confirm its status | Clermont-Ferrand | France | Unknown status |
| CHU Grenoble, Hôpital Michallon Coordinator of this site? Confirm its status | Grenoble | France | Unknown status |
| Hospices Civiles de Lyon, groupement hospitalier Est, Hopital Louis Pradel Coordinator of this site? Confirm its status | Lyon | France | Unknown status |
| CHU Saint-Etienne, CHU Hopital Nord Coordinator of this site? Confirm its status | Saint-Etienne | France | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.